Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Transaction in Own Shares

4 Aug 2021 07:00

RNS Number : 4711H
Allied Minds PLC
04 August 2021
 

4 August 2021

 

Allied Minds

 

Transaction in own shares

 

Allied Minds plc (AIM:ALM, 'Allied Minds' or 'the Company') announces that, in accordance with the terms of its share buyback programme announced on 23 June 2021 ("Share Buyback Programme"), the Company purchased the following number of its Ordinary Shares of £0.01 each ("Ordinary Shares") through Numis Securities Limited. The Ordinary Shares purchased will be cancelled.

 

Date of purchase:

 3 August 2021

Aggregate number of Ordinary Shares purchased:

79,075

Lowest price paid per share (GBp):

20.100

Highest price paid per share (GBp):

20.500

Average price paid per share (GBp):

20.4642

 

Following the purchase of these shares, the remaining number of Ordinary Shares in issue will be 239,884,714 (excluding treasury shares), and the Company hold no Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 239,884,714. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Share Buyback Programme.

 

Schedule of Purchases - Individual Transactions

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

1756

20.50

08:37:42

00053036872TRLO0

LSE

485

20.50

13:27:59

00053050578TRLO0

LSE

5000

20.50

13:27:59

00053050580TRLO0

LSE

3093

20.50

13:27:59

00053050581TRLO0

LSE

6533

20.50

13:42:24

00053050996TRLO0

LSE

4498

20.50

13:42:24

00053050997TRLO0

LSE

6533

20.50

14:02:50

00053051672TRLO0

LSE

1240

20.50

14:02:50

00053051673TRLO0

LSE

6533

20.50

14:27:50

00053052481TRLO0

LSE

2182

20.50

14:27:50

00053052482TRLO0

LSE

6533

20.50

14:57:50

00053054359TRLO0

LSE

1823

20.50

14:57:50

00053054360TRLO0

LSE

1670

20.50

15:10:50

00053054902TRLO0

LSE

6202

20.50

15:10:50

00053054903TRLO0

LSE

331

20.50

15:29:50

00053056129TRLO0

LSE

7854

20.50

15:29:50

00053056130TRLO0

LSE

6533

20.50

15:39:50

00053056606TRLO0

LSE

2028

20.50

15:39:50

00053056607TRLO0

LSE

1130

20.50

15:46:12

00053056868TRLO0

LSE

43

20.50

15:47:44

00053056937TRLO0

LSE

7075

20.10

16:27:50

00053059058TRLO0

LSE

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKZGGRVFDGMZM
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.